AFMD logo

Affimed NV (AFMD)

Profile

Full Name

Affimed N.V.

Ticker Symbol

AFMD

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Germany

IPO

September 12, 2014

Indexes

Not included

Website

http://www.affimed.com

Employees

76

Key Details

Price

$0.79(+27.15%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$8.96M(-79.46% YoY)

Annual EPS

-$7.68(-20.50% YoY)

PE ratio

-

Next earnings date

Jun 12, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.79
AFMD price is $0.79

30-Day Relative Volume

3.77
AFMD 30-day relative volume is 3.77

Price Performance

Price Today change

+27.15%
AFMD price is up +27.15% today

Price YTD change

-33.54%
AFMD price is down -33.54% since January 1st

Price 1-year change

-86.25%
AFMD price is down -86.25% year-on-year

Price 3-year change

-98.11%
AFMD price is down -98.11% over the past 3 years

Price Range

Price All-time high

$242.00
AFMD price is currently -99.67% below its historical high of $242.00

Price 3-year low

$0.52
AFMD price is currently +52.10% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$12.96M
AFMD market capitalization is $12.96 million

Market cap 3-year change

-97.49%
AFMD market capitalization is down -97.49% over the past 3 years

Market cap All-time high

$1.36B
AFMD market capitalization is currently -99.04% below its historical high of $1.36 billion

Market cap sector rank

23.01%
AFMD market capitalization is higher than 23.01% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+7.65%
AFMD shares outstanding is up +7.65% year-on-year

Shares Outstanding 3-Year Change

+32.79%
AFMD shares outstanding is up +32.79% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.33
AFMD beta is 1.33

200-day SMA

$2.70
AFMD price is currently -70.69% below its 200-day simple moving average

50-day SMA

$0.90
AFMD price is currently -11.91% below its 50-day simple moving average

RSI

52.02
AFMD 14-day relative strength index is 52.02

Volume

3.77
AFMD 30-day relative volume is 3.77

ATR

$0.08
AFMD average true range is $0.08

10-day Historical Volatility

170.45%
AFMD 10-day historical volatility is 170.45%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$8.96M
AFMD annual revenue is $8.96 million

Revenue Analysts estimate

$779.75K
AFMD annual revenue is currently +1048.91% higher than the consensus analysts' forecast

Revenue 1-year change

-79.46%
AFMD annual revenue is down -79.46% year-on-year

Revenue Sector rank

26.32%
AFMD annual revenue is higher than 26.32% of companies in Healthcare sector

EPS

EPS

-$7.68
AFMD annual earnings per share is -$7.68

EPS Analysts estimate

-$4.07
AFMD annual earnings per share is currently +88.44% higher than the consensus analysts' forecast

EPS 1-year change

-20.5%
AFMD annual earnings per share is down -20.5% year-on-year

EPS Sector rank

14.12%
AFMD annual earnings per share is higher than 14.12% of companies in Healthcare sector

Profit

Gross profit

-
AFMD annual gross profit value is unknown

Gross margin

-
AFMD annual gross profit margin value is unknown

Operating profit

-$120.32M
AFMD annual operating income is -$120.32 million

Operating margin

-1343.06%
AFMD annual operating profit margin is -1343.06%

Net income

-$114.69M
AFMD annual net profit is -$114.69 million

Net margin

-1280.22%
AFMD annual net profit margin is -1280.22%

Expenses

Total expenses

$129.28M
AFMD annual total expenses is $129.28 million

Operating expenses

$129.28M
AFMD annual total operating expenses is $129.28 million

Cost of goods sold

-
AFMD annual cost of goods sold value is unknown

Selling, general & administrative expenses

$26.71M
AFMD annual SGA is $26.71 million

Depreciation and amortization

$1.89M
AFMD annual depreciation & amortization is $1.89 million

Interest expense

$1.96M
AFMD annual interest expense is $1.96 million

Income tax

$3200.00
AFMD annual income tax is $3200.00

EBIT & EBITDA

EBIT

-$112.73M
AFMD annual earnings before interest & taxes is -$112.73 million

EBITDA

-$110.84M
AFMD annual EBITDA is -$110.84 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$107.40M
AFMD annual total assets is $107.40 million

Non current assets

$14.34M
AFMD annual long term assets is $14.34 million

Current assets

$93.06M
AFMD annual total current assets is $93.06 million

Cash and cash equivalents

$42.59M
AFMD annual cash & cash equivalents is $42.59 million

Accounts receivable

$5.89M
AFMD annual accounts receivable is $5.89 million

Inventory

$511.80K
AFMD annual inventory is $511.80 thousand

Liabilities

Total liabilities

$43.50M
AFMD annual total liabilities is $43.50 million

Long term liabilities

$14.86M
AFMD annual total long term liabilities is $14.86 million

Current liabilities

$28.64M
AFMD annual total current liabilities is $28.64 million

Accounts payable

$20.91M
AFMD annual accounts payable is $20.91 million

Debt

Total debt

$21.39M
AFMD annual total debt is $21.39 million

Total debt 1-year change

+9.66%
AFMD annual total debt is up +9.66% year-on-year

Long term debt

$14.35M
AFMD annual long term debt is $14.35 million

Short term debt

$7.04M
AFMD annual short term debt is $7.04 million

Equity & Capital

Shareholders equity

$63.90M
AFMD annual stockholders equity is $63.90 million

Book value

$63.90M
AFMD annual book value is $63.90 million

Retained earnings

-$592.64M
AFMD annual retained earnings is -$592.64 million

Working capital

$64.42M
AFMD annual working capital is $64.42 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$119.38M
AFMD annual cash flow from operations is -$119.38 million

Cash from operations 1-year change

-7.92%
AFMD annual cash flow from operations is down -7.92% year-on-year

Cash from investing

-$39.04M
AFMD annual cash flow from investing activities is -$39.04 million

Cash from investing 1-year change

-760.43%
AFMD annual cash flow from investing activities is down -760.43% year-on-year

Cash from financing

-$6.73M
AFMD annual cash flow from financing activities is -$6.73 million

Cash from financing 1-year change

-107.21%
AFMD annual cash flow from financing activities is down -107.21% year-on-year

CAPEX

CAPEX

$4.04M
AFMD annual capital expenditures is $4.04 million

CAPEX 1-year change

+450%
AFMD annual capital expenditures is up +450% year-on-year

Free Cash Flow

Free cash flow

-$123.42M
AFMD annual free cash flow is -$123.42 million

Free cash flow 1-year change

-10.83%
AFMD annual free cash flow is down -10.83% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
AFMD annual gross profit margin value is unknown

Operating margin

-1343.06%
AFMD annual operating profit margin is -1343.06%

Net margin

-1280.22%
AFMD annual net profit margin is -1280.22%

ROA & ROE

ROA

-71.14%
AFMD annual return on assets is -71.14%

ROE

-100.66%
AFMD annual return on equity is -100.66%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
AFMD price to earnings ratio value is unknown

PE ratio Sector rank

-
AFMD price to earnings ratio is unknown

PB Ratio

PB ratio

0.68
AFMD price to book ratio is 0.68

PB ratio Sector rank

35.77%
AFMD price to book ratio is higher than 35.77% of companies in Healthcare sector

PS Ratio

PS ratio

13.65
AFMD price to sales ratio is 13.65

PS ratio Sector rank

83.59%
AFMD price to sales ratio is higher than 83.59% of companies in Healthcare sector

Enterprise value

Enterprise value

$19.09M
AFMD enterprise value is $19.09 million

Enterprise value Sector rank

31.71%
AFMD enterprise value is higher than 31.71% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.27
AFMD EV/EBITDA is -0.27

EV/EBITDA Sector rank

56.73%
AFMD EV/EBITDA is higher than 56.73% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

3.25
AFMD annual current ratio is 3.25

Quick ratio

3.23
AFMD annual quick ratio is 3.23

Leverage

Debt to equity

0.21
AFMD annual debt to equity ratio is 0.21

Interest coverage ratio

-57.66
AFMD annual interest coverage ratio is -57.66

Risk & Stability

Piotroski F-Score

-
AFMD piotroski f-score value is unknown

Altman Z-Score

-10.21
AFMD altman z-score is -10.21

Analyst ratings

Recent major analysts updates

Dec 12, 24 Wells Fargo
Overweight
Dec 10, 24 HC Wainwright & Co.
Buy
Nov 19, 24 Cantor Fitzgerald
Overweight
Nov 15, 24 Stifel
Hold
Nov 15, 24 HC Wainwright & Co.
Buy
Nov 15, 23 HC Wainwright & Co.
Buy
Sep 25, 23 Cantor Fitzgerald
Overweight
Sep 12, 23 Cantor Fitzgerald
Overweight
Sep 7, 23 Cantor Fitzgerald
Overweight
Aug 11, 23 Truist Securities
Buy

Institutional Ownership

Similar stocks

ORGS logo
Orgenesis (ORGS)
BLRX logo
BioLineRx (BLRX)
NERV logo
Minerva Neurosciences (NERV)
TLPH logo
Talphera (TLPH)
Kindly MD (KDLY)
HCWB logo
HCW Biologics (HCWB)
TRAW logo
Traws Pharma (TRAW)
HCTI logo
Healthcare Triangle (HCTI)
BSGM logo
BioSig Technologies (BSGM)
  • What is the ticker symbol for Affimed NV?
  • Does Affimed NV pay dividends?
  • What sector is Affimed NV in?
  • What industry is Affimed NV in?
  • What country is Affimed NV based in?
  • When did Affimed NV go public?
  • Is Affimed NV in the S&P 500?
  • Is Affimed NV in the NASDAQ 100?
  • Is Affimed NV in the Dow Jones?
  • When was Affimed NV's last earnings report?
  • When does Affimed NV report earnings?

What is the ticker symbol for Affimed NV?

The ticker symbol for Affimed NV is NASDAQ:AFMD

Does Affimed NV pay dividends?

No, Affimed NV does not pay dividends

What sector is Affimed NV in?

Affimed NV is in the Healthcare sector

What industry is Affimed NV in?

Affimed NV is in the Biotechnology industry

What country is Affimed NV based in?

Affimed NV is headquartered in Germany

When did Affimed NV go public?

Affimed NV's initial public offering (IPO) was on September 12, 2014

Is Affimed NV in the S&P 500?

No, Affimed NV is not included in the S&P 500 index

Is Affimed NV in the NASDAQ 100?

No, Affimed NV is not included in the NASDAQ 100 index

Is Affimed NV in the Dow Jones?

No, Affimed NV is not included in the Dow Jones index

When was Affimed NV's last earnings report?

Affimed NV's most recent earnings report was on Nov 14, 2024

When does Affimed NV report earnings?

The next expected earnings date for Affimed NV is Jun 12, 2025
On this page